AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2007
Feb 20, 2007
29875_dirs_2007-02-20_995b56eb-804d-4db9-9a4a-235d82cf1b40.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CORP (CVS)
CIK: 0000064803
Period of Report: 2007-02-12
Reporting Person: SGARRO DOUGLAS A (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-02-12 | Stock Unit | A | 7863 | — | Acquired | 28779 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 126003 | Direct |
| Common Stock (Restricted) | 55317 | Direct |
| ESOP Preference Stock | 387 | Indirect |
| Common Stock | 9532 | Indirect |
Footnotes
F1: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan.
F4: Includes dividend reinvestment shares acquired during the course of the year.
F3: Reflects stock beneficially owned pursuant to issuer's ESOP Plan.
F2: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Declaration of Voting Results & Voting Rights Announcements
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3